tad 600 glutathione (TAD) 600mg/4mL IV/IM SALE! New TAD-600 FDA Approved

CagriSema Clinical Trials Evidence CagriSema's evidence base is unusually strong for a peptide research stack: two large Phase 3 trials with NEJM publications, plus Phase 1b/2 supporting data

For health professionals working with clients interested in peptide research, understanding proper dosing protocols is essential

M., Verly Junior, E., & Costa, M

The Discovery Rabbit Thalamic Stimulation (1977) The original 1977 isolation by the Schoenenberger-Monnier group at Basel confirmed DSIP as a nonapeptide of MW 849 Da inducing primarily delta-sleep in rabbits, rats, mice, and humans with a more pronounced effect on REM sleep observed in cats establishing the species-dependent variation in DSIPs sleep-promoting profile that remains relevant to experimental design today